GlassScriptPhysician profile
Damond Blueitt
NPI 1790949352
$4,703.23
in general payments reported to CMS, 2019-2025
24 companies · $712 in 2025
The $712 reported for 2025 was more than what 87% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $73.21 · 2021: $1,929 · 2022: $650 · 2023: $323 · 2024: $642 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,677.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,209.97 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $838.07 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $627.18 | 2019-2025 | Euflexxa |
| Pacira Therapeutics, INC. | $443.74 | 2019-2021 | |
| Depuy Synthes Sales INC. | $362.45 | 2019-2025 | Monovisc, Orthovisc, Dynacord |
| Abanza INC. | $253.60 | 2024 | Kischner Wire, Washercap Fixation System 10mm |
| Bioventus LLC | $145.64 | 2021-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Medical Device Business Services, INC. | $109.33 | 2024 | Truespan Orthocord, Dynacord, Healix Knotless Peek |
| Medacta USA, INC. | $97.03 | 2024-2025 | Gmk Sphere |
| Vertex Pharmaceuticals Incorporated | $90.83 | 2025 | |
| Trimed, INC. | $83.50 | 2025 | |
| Orthofix Medical, INC. | $73.49 | 2019-2025 | Physio-Stim, Spinal-Stim |
| Davol INC. | $69.31 | 2023-2025 | Arista |
| Hydrocision, INC. | $56.49 | 2021-2024 | Tenjet |
| Horizon Therapeutics Plc | $45.60 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $42.13 | 2023-2025 | Caldolor |
| Fidia Pharma USA INC. | $24.62 | 2019 | |
| Sanofi-Aventis U.S. LLC | $24.05 | 2019-2020 | |
| Smith+Nephew, INC. | $21.70 | 2024 | Renasys Touch |
| Kerecis Limited | $20.46 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Radius Health, INC. | $18.06 | 2019 | |
| Medtronic, INC. | $16.79 | 2025 | Inceptiv |
| Nevro Corp. | $15.89 | 2021 | |
| Sanara Medtech INC. | $13.30 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damond Blueitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.